ArticleInternational journal of molecular sciences2025

Knockdown of Claudin-8 (CLDN8) Indicates a Link Between Breast Cancer Cell Sensitivity to Chemotherapeutics and Reveals a Potential Use of CLDN8 as a Molecular Diagnostic and Target for Therapy.

Wenxiao Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.